Eden Prairie-based Surmodics' stock soared Wednesday following news of its impending sale that will take the medical device company private. Private equity firm GTCR, based in Chicago, will pay $627 million or $43 per share for Surmodics when the transaction closes in the second half of the year, pending shareholder and regulatory approval. Health care and technology make up a main sector of ...

Related Keywords

Chicago , Illinois , United States , Sean Cunningham , Gary Maharaj , Mike Matson , Drug Administration , Exchange Commission , Needham Co , Medtronic , Eden Prairie Based Surmodic , Boston Based Needham , Brookso Neil , Minneapolis Based Lake Street Capital , Ireland Based Vetex Medical ,